Austrade will shortly be calling on stakeholders to provide feedback on its Clinical Trial Industry Capability Report (ICR).
The ICR is designed to highlight Australia's capability and strengths in clinical trials to an international audience.
It will include an outline of the Australian-based clinical trials industry, case studies, and a capability matrix, listing Australian organisations against specific categories of capability.
According to Austrade, it will use the report to showcase Australia's capability to pharmaceutical, biotechnology and medical device companies at its international posts. Copies of Austrade's existing health and wellbeing ICRs can be viewed at its website.
Companies interested in being included in the matrix should lodge an expression of interest at Austrade's website by Thursday 2 April.